Preliminary indications support safety and efficacy of 90Y-labeled lintuzumab in AML Dec. 10, 1998 No Comments
Coulter and SB enter agreement to develop and commercialize I-131 anti-B1 antibody Dec. 4, 1998 No Comments
RSS